Biomedical Development Corporation
15
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.4% vs industry average
7%
1 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUD
Role: collaborator
KIOS Mobile App Evaluation
Role: collaborator
Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder
Role: lead
mHealth for Patient Self-Management of Opioid Use Disorder
Role: lead
Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods
Role: collaborator
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Role: collaborator
Efficacy of Iocide Oral Rinse Against Gingival Inflammation
Role: lead
Relationship Between Vestibular Function and Topographic Memory
Role: lead
Dose-Response Study of Iocide Oral Rinse
Role: lead
Exploratory Study of Iocide Oral Rinse in a Diabetic Population
Role: lead
New Topical Treatment for Continued Pain After Shingles
Role: lead
Treatment and/or Prevention of Urinary Tract Infections
Role: lead
Novel Topical Treatment of Hand Dermatitis (Eczema)
Role: lead
Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
Role: lead
Pilot Efficacy Study to Treat Gingivitis
Role: lead
All 15 trials loaded